The generic name of Ganlixin is Diammonium Glycyrrhizinate Capsules, Diammonium Glycyrrhizinate Enteric Tablets and Diammonium Glycyrrhizinate Capsules only differ in dosage form, and are otherwise the same. Diammonium glycyrrhizinate has anti-inflammatory, hepatocyte protection and liver function improvement effects, and can be used for the treatment of acute and chronic hepatitis accompanied by elevated ghrelin aminotransferase; however, it is contraindicated in patients with allergy to the drug, severe hypokalemia, hypernatremia, heart failure, hypertension, renal failure and so on. Diammonium glycyrrhizinate enteric tablets and diammonium glycyrrhizinate capsules are only the difference in dosage form enteric tablets are added a layer of enteric coating, while the capsule is the drug into the capsule, the other components, indications and other aspects are the same. Patients who need to use diammonium glycyrrhizinate enteric-coated tablets or diammonium glycyrrhizinate capsules for treatment should use them under the guidance of a doctor.